The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative Colitis

The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative Colitis

Branched-chain amino acids (BCAAs) are involved in immune system’s metabolic pathways and play fundamental role in gut health. Our aim was to assess BCAA plasma levels in patients with ulcerative colitis (UC) and associations of plasma BCAAs with disease-related parameters. This was a case-control s...

Full description

Bibliographic Details
Main Authors:	Efstathia Papada, Charalampia Amerikanou, Aristea Gioxari, Nick Kalogeropoulos, Andriana C. Kaliora
Format:	Article
Language:	English
Published:	MDPI AG 2020-10-01
Series:	Diagnostics
Subjects:	BCAAs ulcerative colitis inflammation calprotectin
Online Access:	https://www.mdpi.com/2075-4418/10/10/798

Similar Items

Clinical and inflammatory biomarkers of inflammatory bowel diseases are linked to plasma trace elements and toxic metals; new insights into an old concept
by: Charalampia Amerikanou, et al.
Published: (2022-12-01)

Editorial: Recent advances and new biomarkers in ulcerative colitis
by: Tsvetelina Velikova, et al.
Published: (2023-05-01)

Relationship between Fecal Calprotectin Level and Colonoscopy Findings in Ulcerative Colitis Patients Referred to the Gastroenterology Clinic, Gorgan, Iran (2020)
by: Maryam Esmailpour, et al.
Published: (2023-07-01)

An Absorption and Plasma Kinetics Study of Monoterpenes Present in Mastiha Oil in Humans
by: Efstathia Papada, et al.
Published: (2020-07-01)

Intermittent Fasting and Reduction of Inflammatory Response in a Patient with Ulcerative Colitis
by: Ángel Roco-Videla, et al.
Published: (2023-08-01)

Milan Ultrasound Criteria Predict Relapse of Ulcerative Colitis in Remission
by: Masa Maeda, et al.
Published: (2023-07-01)

Utility of fecal calprotectin as a discriminative biomarker between ulcerative colitis and irritable bowel syndrome and its ability to be used for the assessment of the remission stage of ulcerative colitis
by: Hossam M Elsaadany, et al.
Published: (2016-01-01)

Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity
by: Hauke Christian Tews, et al.
Published: (2023-10-01)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
by: Corina Silvia Pop, et al.
Published: (2020-12-01)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
by: Hamid Kalantari, et al.
Published: (2015-01-01)

Altered fecal bile acid composition in active ulcerative colitis
by: Stefanie Sommersberger, et al.
Published: (2023-11-01)

iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis
by: Ferdinando D’Amico, et al.
Published: (2023-02-01)

Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis
by: Hsu-Heng Yen, et al.
Published: (2020-07-01)

Fecal calprotectin as an indicator in risk stratification of pouchitis following ileal pouch–anal anastomosis for ulcerative colitis
by: Rui-Bin Li, et al.
Published: (2023-12-01)

Effect of disease duration on fecal biomarkers in ulcerative colitis: a prospective cohort study
by: Natsuki Ishida, et al.
Published: (2022-09-01)

Enhancing Calprotectin’s Predictive Power as a Biomarker of Endoscopic Activity in Ulcerative Colitis: A Machine Learning Use Case
by: Mihaela Dranga, et al.
Published: (2024-02-01)

Role of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis
by: Silvia Espina, et al.
Published: (2022-12-01)

Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis
by: Yoshihiro Tatsumi, et al.
Published: (2023-11-01)

Evaluating Serum Calprotectin and Serum Oncostatin M Levels as Diagnostic Markers in Crohn's Disease and Ulcerative Colitis Iraqi Patients. Research
by: Yahya G. Karwi, et al.
Published: (2024-04-01)

Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases
by: Aristea Gioxari, et al.
Published: (2020-12-01)

Evaluation of the diagnostic performance of estimated fecal calprotectin and serum intelectin-1 and C-reactive protein solo or in combination for differentiation between patients with query ulcerative colitis and irritable bowel syndrome
by: Rizk Sayad R. Sarhan, et al.
Published: (2023-11-01)

Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
by: Alix Démaris, et al.
Published: (2022-09-01)

Ulcerative colitis in infancy
by: Md Rukunuzzaman, et al.
Published: (2011-01-01)

Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of Induction
by: Geert D'Haens, et al.
Published: (2023-06-01)

Ulcerative Colitis: A Challenge to Surgeons
by: Fazl Q Parray, et al.
Published: (2012-01-01)

Endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study
by: Annamaria Pronio, et al.
Published: (2016-04-01)

Specific Alteration of Branched-Chain Amino Acid Profile in Polycystic Ovary Syndrome
by: Katarzyna Paczkowska, et al.
Published: (2023-01-01)

Prevalence of Entamoeba Histolytica infection in patients with colitis (Ulcerative and Infective)
by: Luay I. Farhan Al-Rwi, et al.
Published: (2016-10-01)

Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease
by: Santo Colosimo, et al.
Published: (2023-09-01)

Micronutrient deficiency among patients with ulcerative colitis
by: Amany Hussien, et al.
Published: (2022-11-01)

Thrombotic cutaneous gangrene associated with ulcerative colitis
by: Justine Galambus, BS, et al.
Published: (2022-10-01)

Anti-integrin treatment as an effective alternative for a patient with ulcerative colitis
by: Ewa Biegańska, et al.
Published: (2022-12-01)

Nutrition and Supplementation in Ulcerative Colitis
by: Marcelina Radziszewska, et al.
Published: (2022-06-01)

Ulcerative colitis – recent and potential methods of treatment - review
by: Mikołaj Tomasik, et al.
Published: (2023-01-01)

Food Avoidance in Patients with Ulcerative Colitis: A Review
by: Davood Mehrabani, et al.
Published: (2017-12-01)

Appendiceal Mucocele Detected under Treatment of Ulcerative Colitis
by: Rohta Noaki, et al.
Published: (2009-11-01)

Branched-Chain Amino Acids (BCAAs) - oral supplementation and its effects in resistance training and treatment
by: Borys Bieńkowski, et al.
Published: (2023-08-01)

Is Infection Associated With Ulcerative Colitis Activity?
by: Ayoung Lee, et al.
Published: (2024-03-01)

Lymphocyte-to-Monocyte Ratio as a Marker for Endoscopic Activity in Ulcerative Colitis
by: Natsuki Ishida, et al.
Published: (2021-10-01)

Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis
by: Hiroaki Kitae, et al.
Published: (2022-05-01)